← Back to headlines
Tarsus Reaffirms 2026 Sales Guidance as XDEMVY Posts Strong Q1 Sales
Tarsus has reiterated its 2026 net product sales guidance of $670 million-$700 million, following strong first-quarter sales of $145.4 million for its product XDEMVY.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
